Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Dexcom, Inc.
EIR
•Dexcom, Inc.•March 22, 2018

Dexcom, Inc. – FDA EIR, Mar 22, 2018

Record Details

An FDA Pre-Approval Inspection was conducted at Dexcom, Inc.'s Mesa, AZ facility from March 19-22, 2018. The primary purpose of this inspection, performed under the regulatory framework of a Pre-Market Approval (PMA P120005/S067), was to assess the Mesa site as a new, second manufacturing location for components of the Dexcom G4 Platinum and G5 Mobile Continuous Glucose Monitoring Systems. Specifically, the inspection focused on the manufacturing processes for the sensor and transmitter parts of these critical medical devices. The inspection also included an abbreviated Quality System Inspection Technique (QSIT) evaluation, examining the company’s Management Review, Corrective and Preventive Action (CAPA), and Production and Process Controls subsystems. A significant finding of the inspection was that no FDA-483, indicating observations of significant violations or deficiencies, was issued. The report explicitly stated that 'Facilities and Controls were acceptable,' signifying that the site's operations met regulatory standards at the time of inspection. Consequently, the FDA determined that no further actions were required from Dexcom, Inc. The company was advised to continue its commitment to maintaining robust quality systems and vigilant oversight as its Mesa operations expand.

Company
Dexcom, Inc.
Inspection date
March 22, 2018
Product type
devices
Office
Center for Devices and Radiological Health
People
  • Kevin R. Sayer (recipient)
  • Trent Davalos (company_representative)
  • Justino Gomez (company_representative)
  • James R. Kasselman (recipient)
  • Christina Orsini (company_representative)
View Company Profile

ID · 904a9525-4d87-4f21-b1ee-0fd944b0a770

Violation Codes1
21 CFR 820.30

Full citation text and observation details available on the Dashboard.

Other documents for Dexcom, Inc.
  • 483 - 2024-11-07November 7, 2024
  • 483 - 2024-06-14June 14, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dexcom, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.